Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pharmabiome AG has 1 pending office action currently active in the Biotechnology & Pharmaceuticals technology area. This portfolio shows a high degree of concentration, as it involves only 1 distinct examiner and 1 distinct art unit. This singular focus indicates that the company's current patent efforts are being reviewed by a very specific technical group at the USPTO. The alignment with 1 art unit suggests that the innovations are being judged within a tightly defined biological context.
The busiest examiner for this portfolio is EDWARDS, JESSICA FAYE, who is handling 1 pending office action. As this is the only pending matter, this examiner represents the sole point of interaction for the company's current prosecution. Practitioners should note that the progress of the portfolio is tied to the specific art unit and examiner assigned. The data reflects a streamlined prosecution environment with no current diversification across different examiners or technical units. Because EDWARDS, JESSICA FAYE is the busiest examiner with 1 pending action, the entire weight of the company's current USPTO engagement rests on this single relationship. This concentration simplifies the administrative burden but increases the impact of this specific examiner's individual methodology.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EDWARDS, JESSICA FAYE | 1 | 39.1% | +46.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17285112 | METHOD OF MANUFACTURING A CONSORTIUM OF BACTERIAL STRAINS | EDWARDS, JESSICA FAYE | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17285112 | METHOD OF MANUFACTURING A CONSORTIUM OF BACTERIAL STRAINS | EDWARDS, JESSICA FAYE | 1657 | §103§112DP | Non-Final OA | — | Pending | Apr 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial